| 000 | 01152 a2200325 4500 | ||
|---|---|---|---|
| 005 | 20250514170811.0 | ||
| 264 | 0 | _c20040430 | |
| 008 | 200404s 0 0 eng d | ||
| 022 | _a0342-4642 | ||
| 024 | 7 |
_a10.1007/s00134-003-2135-y _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aIoanas, Malina | |
| 245 | 0 | 0 |
_aLinezolid in VAP by MRSA: a better choice? _h[electronic resource] |
| 260 |
_bIntensive care medicine _cMar 2004 |
||
| 300 |
_a343-6 p. _bdigital |
||
| 500 | _aPublication Type: Comment; Editorial | ||
| 650 | 0 | 4 |
_aAcetamides _xpharmacology |
| 650 | 0 | 4 |
_aAnti-Infective Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aCross Infection _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aLinezolid |
| 650 | 0 | 4 |
_aMethicillin Resistance _xphysiology |
| 650 | 0 | 4 |
_aOxazolidinones _xpharmacology |
| 650 | 0 | 4 |
_aPneumonia, Staphylococcal _xdrug therapy |
| 650 | 0 | 4 |
_aRespiration, Artificial _xadverse effects |
| 650 | 0 | 4 |
_aVancomycin _xpharmacology |
| 700 | 1 | _aLode, Hartmut | |
| 773 | 0 |
_tIntensive care medicine _gvol. 30 _gno. 3 _gp. 343-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00134-003-2135-y _zAvailable from publisher's website |
| 999 |
_c14491076 _d14491076 |
||